The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-24.4% to $88.00
Predicted High$110.50in 2 weeks
Predicted Low$88.00at 6 months
Max Drawdown (predicted)-24.4%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Jul 29, 2026 12:41 am
Bear
SPCX trends lower to
$88.00
(-24.4% from $116.41)
by Jan 2027.
decay
ThesisSPCX is a post-IPO SpaceX proxy with deeply negative value and sentiment scores, a jittery risk-off tape, and a beta near 4.5 that amplifies every macro wobble. With no earnings catalyst and air actively leaving the narrative, the path should drift lower with a bounce attempt that fails, ending well below current levels but far above the bear anchor.
Invalidated ifA decisive close back above $130 on heavy volume, or a broad risk-on regime flip, would falsify the continued bleed.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $116.41 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Jul 29, 2026
—
$116.41at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 12, 2026
$90.67–$142.15typical range · internal point $110.50
—
±22.1%
6/10
Momentum and sentiment bleed continues in neutral tape
What actually happened:
closed $133.29
on Aug 11, 2026 = +14.5% vs the call
(predicted -5.1%)
· direction MISS
(called down, was up)
· off by 19.6 pp
· accuracy 4/10
· typical range ±22.1%:
inside the band
· S&P +5.6%
over the same window — lagged it
1 month
Aug 29, 2026
$79.11–$153.71typical range · internal point $105.00
—
±32.0%
6/10
High-beta selling pressure, no catalyst to stop drift
2 months
Sep 29, 2026
$101.00
—
-13.2%
5/10
Post-IPO lockup and narrative fatigue weigh further
3 months
Oct 29, 2026
$108.00
—
-7.2%
4/10
Oversold bounce attempt on any macro relief
4 months
Nov 29, 2026
$98.00
—
-15.8%
4/10
Bounce fades, value gravity toward attractive zone reasserts
5 months
Dec 29, 2026
$92.00
—
-21.0%
4/10
Year-end tax selling in weak high-beta names
6 months
Jan 29, 2027
$88.00
—
-24.4%
3/10
Slow grind toward fair-value zone continues into 2027
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.